This publication is a summary of a recent
presentation in Auckland by Dr Robin Emsley
from the University of Stellenbosch, Cape
Town, South Africa on the management of
schizophrenia, with particular focus on the
use of long-acting injectable risperidone
(Risperdal® Consta®; Janssen-Cilag) in
achieving sustained remission in early
disease.
Download PDF